A phase III clinical trial tested the effectiveness of a combination of two drugs and found they may be an effective and safe treatment for patients with metastatic breast cancer.
By rotating special magnetic nanoparticles injected into brain tumors, a team of scientists led by Northwestern Medicine neurosurgical oncologist Maciej (Matt) Lesniak, MD, successfully damaged tumor cells in animal models.
Patients with cancer who watched personalized educational videos before their first visit with an oncologist were better equipped to consider participating in clinical trials, reports a paper co-authored by Northwestern Medicine investigator Al B. Benson, III, MD.
Northwestern University scientists used fruit fly genetics to understand how developing cells normally switch to a restricted, or specialized, state and how that process might go wrong in cancer.
First-year medical student Martin Mutonga was the first author of a recent paper that identified a potential drug target in acute lymphoblastic leukemia.
A recent study led by Elizabeth Perlman, MD, discovered a new genetic mutation in the most common type of pediatric kidney cancer, Wilms tumor.
Research conducted in the laboratory of Derek Wainwright, PhD, assistant professor of Neurological Surgery, explores strategies to reverse pathways that inhibit the body’s immune system from fighting glioblastoma.
Northwestern Medicine scientists have received a five-year, $11 million grant from the National Institutes of Health National Cancer Institute (NCI) to lead a Specialized Program of Research Excellence (SPORE) in prostate cancer.
New neurosurgery chair, Maciej S. Lesniak, MD, MHCM, combats brain cancer with a multifaceted biological approach.
Proteomics, the large-scale study of proteins, is critical to many research projects taking place at the medical school. Plans are in place to expand capabilities on the Chicago campus in 2016, which will help scientists use proteins to make breakthroughs in varied fields of study.